We "sampled" the fluxes using a fixed interval (1 32 days) or a rule-based (decision tree-based) sampling method.
Serum was collected following the interview visit (median interval 40 days), frozen at −80 °C and later analyzed with high-sensitivity ELISA for IL-6.
A pathologic complete response occurred in 19percentt of patients with an interval >44 days, vs. 12percentt in those with an interval < or =44 days ( P = 0.27).
The black line indicates the median value (250 days), and dashed lines are the 95th confidence interval (213 294 days).
Taking the second semester of 2011 as reference, significant decreases in the average lactation length (−6 days, on average) and calving-to-conception interval (−4 days, on average) were observed relative to the same semesters of the years 2010 and 2009, respectively.
Amenorrhoea is defined as an intermenstrual interval >90 days.
The median OS was 364 days (95% confidence interval, 275-452 days) for the PR patients and 350 days (95% confidence interval, 293-406 days) for the SD patients respectively.
The median time to tumour progression was 307 days (95% confidence interval 235 347 days).
The median PFS was 249 days (95% confidence interval, 187-310 days) for the 37 patients with PR and 220 days (95% confidence interval, 191-248 days) for the 117 patients with SD.
Oligomenorrhoea is defined as an intermenstrual interval >35 days or <8 menstrual bleedings in the last year.
